Health Canada approves secukinumab for psoriatic arthritis, ankylosing spondylitis

Health Canada approves secukinumab for psoriatic arthritis, ankylosing spondylitis

Secukinumab has been approved by Health Canada for adult patients with psoriatic arthritis or ankylosing spondylitis who responded inadequately to prior treatment with conventional therapy, according to a press release from Novartis.

(Visited 3 times, 1 visits today)
1
Like
Save

Comments

Write a comment